25 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/apnimed-expands-portfolio-of-oral-pharmacotherapies-for-sleep-and-breathing-diseases-through-acquisition-of-global-rights-to-patents-covering-sulthiame-a-differentiated-carbonic-anhydrase-inhibitor-302438325.html